Dose daily

VELMENI Secures FDA Nod for Advanced AI-Driven 3D Dental Imaging

Sunnyvale, California-based dental AI firm VELMENI announced on July 23, 2026, that the U.S. FDA has granted 510(k) clearance for its latest software, VELMENI for DENTISTS (V4D) 3D. The...

Oriflame India Transfers Manufacturing Operations to Akums Subsidiary Pure & Cure

Oriflame India has signed an agreement to transfer its Indian manufacturing operations to Pure and Cure Healthcare, a wholly...

Major Raid in Dehradun as Fake Medicines Worth ₹5 Crore Seized

In a major strike against illegal drug trafficking, a joint operation by the Uttar Pradesh Food Safety and...

RPG Life Sciences Partners With Archerchem to Launch Naprosyn ES in India

RPG Life Sciences has announced a new collaboration with Archerchem Healthcare to bring Naprosyn ES, a first-of-its-kind fixed combination of...

Manipal Health to Launch Massive IPO – $8 Billion Valuation Target

Manipal Health, one of India’s leading healthcare providers, has announced its upcoming Initial Public Offering (IPO) with a...

India’s CDSCO Bans Injectable Products From Being Marketed as Cosmetics

The Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, has issued a...

Sun Pharma Reports Strong Q4 with 26% Growth in Net Profit

Sun Pharmaceutical Industries Limited reported a strong fourth quarter for FY26, with consolidated net profit rising 26.2% year-on-year to ₹2,714 crore. Revenue for the quarter...

West Bengal Healthcare Gets Major Boost as Centre Reviews Key Health Schemes

Union Health Minister Jagat Prakash Nadda held a virtual review meeting with West Bengal officials to assess the state’s healthcare systems and discuss ways to strengthen...

J P Nadda Speaks on TB Prevention at Geneva Global Health Summit

India reinforced its commitment to tuberculosis prevention and stronger lung health screening as Union Health Minister Jagat Prakash Nadda addressed a key side-event on “Ministerial Perspectives...

Dr. Reddy’s Launches Affordable Oral Diabetes Drug in India

Dr. Reddy’s Laboratories has announced the launch of Obeda®, its oral semaglutide tablet for the treatment of Type 2 diabetes in India. The once-daily tablet...

North Bengal Set to Transform into a Leading Pharma Destination

West Bengal is intensifying its focus on pharmaceutical manufacturing as part of a broader industrial development strategy aimed at attracting investment and boosting economic...